Delivery Order SPE2DR25D1021-SPE2DR26FNL8C
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,944.66 by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order awarded without any set-aside designation, reflecting a competitively awarded...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,494.17 by the Defense Logistics Agency on July 31, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a 0.5 ml dosage. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded through open competition. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- On August 14, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $24,309.79 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injections. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $5,405.40 by the Defense Logistics Agency on September 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract carries a firm fixed price structure with an ultimate completion date of September 12, 2025, and utilizes no set-aside designation. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,414.82. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was awarded without a set-aside designation through competitive procurement. Performance will be executed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $2,026.98. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is scheduled for completion by October 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- AmerisourceBergen Drug Corp was awarded a firm fixed price delivery order valued at $1,788.24 by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL). The contract, which represents a non-competitive set-aside delivery, is scheduled for completion by October 31, 2025, with performance based in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 3 mg/0.5 ml pen injections, valued at $1,641.36, with an ultimate completion date of July 22, 2025. The contract was competitively awarded on July 21, 2025, using firm fixed pricing with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a single pharmaceutical procurement under...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml) with a ceiling value of $1,041.84. This is a firm fixed price, non-competitive delivery order funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This...
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNL8CDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 31, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injections. The contract, valued at $4,379.01, represents a firm fixed price delivery order with an ultimate completion date of November 3, 2025. The place of performance is identified as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This award was competitively awarded without set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. The Trulicity order exemplifies the types of specialty medications—in this case, a diabetes treatment—that AmerisourceBergen routinely delivers to federal customers including the Defense Health Agency and other government healthcare systems through this flexible contracting arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 10/31/25 |